Author: Inspire Malibu

Inspire Malibu is the premier Non 12 Step, drug, alcohol, and detox treatment center in Agoura Hills, California. Our state-of-the-art treatment program combines the latest scientific research with proven, evidence-based therapies to address both alcohol and substance abuse successfully. Inspire Malibu is Joint Commission (JCAHO) accredited and has been designated a Higher Level of Care by the Department of Health Care Services. We are also uniquely qualified to address dual-diagnosis disorders.
Posted in
Posted in

What is Phenibut and Why Did the FDA Issue a Warning About its Dangers?

Using dietary supplements, such as fish oil, multivitamins, and other over-the-counter health-related products is a daily habit for many Americans. In fact, dietary supplements are big business. According to the FDA, there are an estimated 75,000 different products sold as dietary supplements, purchased by more […]

CONTINUE READING What is Phenibut and Why Did the FDA Issue a Warning About its Dangers? 4 min read

SBIRT – Screening, Brief Intervention and Referral to Treatment for Substance Use

The prevalence of addiction in the United States, from tobacco use to alcoholism, and the opioid epidemic to other illicit drug abuse, takes a costly toll on the nation’s physical, emotional and financial wellbeing. The National Institute on Drug Abuse (NIDA) estimates the price of […]

CONTINUE READING SBIRT – Screening, Brief Intervention and Referral to Treatment for Substance Use 3 min read
Posted in
Posted in

National Alcohol and Other Drug-Related Birth Defects Awareness Week

May 10 to 16, 2020 Mother’s Day marks the beginning of National Alcohol and Other Drug-Related Birth Defects Awareness Week, sponsored by the National Council on Alcoholism and Drug Dependence (NCADD). This nationwide campaign hopes to raise awareness and educate people, especially women, of the […]

CONTINUE READING National Alcohol and Other Drug-Related Birth Defects Awareness Week 3 min read
Posted in
Posted in

Spravato® (Esketamine) for Treatment Resistant Depression – An FDA Approved “Breakthrough Therapy”

In March 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Spravato® (Esketamine) for use in patients diagnosed with treatment-resistant depression. Spravato® is a nasal spray that can only be administered by an approved health care provider, in the physician’s office or […]

CONTINUE READING Spravato® (Esketamine) for Treatment Resistant Depression – An FDA Approved “Breakthrough Therapy” 4 min read
TOP
Call Now Button Skip to content
WELCOME TO INSPIRE MALIBU
PGlmcmFtZSB3aWR0aD0iODUzIiBoZWlnaHQ9IjQ4MCIgc3JjPSJodHRwczovL215Lm1hdHRlcnBvcnQuY29tL3Nob3cvP209ZHVlNkpBcWFtR1AiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+